Detemir as a once-daily basal insulin in type 2 diabetes

@inproceedings{Nelson2011DetemirAA,
  title={Detemir as a once-daily basal insulin in type 2 diabetes},
  author={Scott E Nelson},
  booktitle={Clinical pharmacology : advances and applications},
  year={2011}
}
BACKGROUND Insulin detemir, a long-acting basal insulin analog, is labeled for once-daily or twice-daily dosing in patients with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus. Protocols for some earlier clinical studies of detemir evaluated twice-daily dosing, which may have generated the misperception that detemir should be prescribed twice daily for most patients. This review examines pharmacokinetic and pharmacodynamic (PK/PD), observational, and controlled studies that have evaluated… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
6 Citations
46 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 46 references

Similar Papers

Loading similar papers…